Access cutting-edge neuromyelitis optica treatment through this clinical trial at a research site in Washington. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Washington location
Preparing your pre-screening questions…
Access neuromyelitis optica specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neuromyelitis optica treatment provided free
Check if you qualify for this neuromyelitis optica clinical trial in Washington, MO
No-Cost Study Care
Local to Washington
Convenient for MO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
NMOSDCopilot is a digital tool developed for the self-assessment of Neuromyelitis Optica Spectrum Disorder symptoms that impact patients' functioning and quality of life. It has been co-designed with the help of patient advocacy groups, NMOSD patients and medical experts. It includes a smartphone-based application for patients, connected to a web portal developed for healthcare professionals (HCSPs). The patient application is composed of vision, walking, cognition, and dexterity e-active tests inspired by clinical standards, as well as e-questionnaires. The HCP web portal is a desktop-based software that allows HCPs to access the results generated via the patient application and facilitates remote monitoring of patients' symptoms. The objectives of this study are to validate the accuracy, reliability and reproducibility of the unsupervised at-home self-assessment of symptoms on the patient's smartphone versus the standard in-clinic testing, as well as to evaluate the safety of use of the tool, its usability, and satisfaction towards the patient application among NMOSD patients, and the HCP web dashboard among HCPs.
Sponsor: Ad scientiam
Yes, this clinical trial (NCT05566769) has an active research site in Washington, MO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for neuromyelitis optica treatment options in Washington, MO, this clinical trial (NCT05566769) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuromyelitis optica specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all neuromyelitis optica clinical trials near you to find additional studies recruiting in your area.
See all interstitial cystitis clinical trials recruiting in Washington — not just this study.
Browse Interstitial Cystitis Trials in Washington →